510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K062937Substantially Equivalent

Transdiscal System, Models Tdp-17-150-6, Tdi-17-150, Tda-Ppu-1, Tda-Tbk-1, Tdx-Y-Tsw-Tdp, Tdx-Pmg-Ppu

Baylis Medical Co., Inc., Mississauga, Ontario, CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K062937 is the FDA 510(k) clearance record for TRANSDISCAL SYSTEM, MODELS TDP-17-150-6, TDI-17-150, TDA-PPU-1, TDA-TBK-1, TDX-Y-TSW-TDP, TDX-PMG-PPU, a class II device, cleared for Baylis Medical Co., Inc. on under FDA product code GXI (Probe, Radiofrequency Lesion). FDA records list 53 510(k) clearances for Baylis Medical Co., Inc., from to . As of , FDA records show one recall naming K062937.

Clearance record

Decision date
Received
(102 days to decision)
Product code
GXI Probe, Radiofrequency Lesion
Regulation
21 CFR 882.4725
Device class
Class II
Review panel
Neurology
Applicant
Baylis Medical Co., Inc. 2580 Matheson Blvd. E, Mississauga, Ontario, CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code GXI

Trailing 12 months
2 clearances under product code GXI in the twelve months to October 2026, February 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code GXI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20261
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260